CN Stock MarketDetailed Quotes

688278 Xiamen Amoytop Biotech

Watchlist
  • 74.49
  • +0.66+0.89%
Market Closed May 12 15:00 CST
30.30BMarket Cap34.39P/E (TTM)

Xiamen Amoytop Biotech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2025
(FY)Dec 31, 2024
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
Total operating revenue
23.48%673.35M
34.13%2.82B
33.90%1.95B
31.68%1.19B
30.05%545.3M
37.55%2.1B
27.69%1.46B
26.40%903.58M
21.53%419.31M
34.86%1.53B
Operating revenue
23.48%673.35M
34.13%2.82B
33.90%1.95B
31.68%1.19B
30.05%545.3M
37.55%2.1B
27.69%1.46B
26.40%903.58M
21.53%419.31M
34.86%1.53B
Total operating cost
21.34%460.73M
31.05%1.88B
30.42%1.3B
27.57%816.75M
24.66%379.69M
23.30%1.44B
14.73%996.11M
17.68%640.25M
17.61%304.58M
27.66%1.16B
Operating cost
21.71%45.96M
31.03%183.51M
38.79%129.93M
23.73%78.97M
0.09%37.77M
-17.24%140.05M
-23.25%93.62M
-14.77%63.82M
3.11%37.73M
35.25%169.24M
Operating tax surcharges
23.38%3.45M
22.23%13.73M
21.45%9.61M
26.78%6.12M
31.27%2.79M
43.30%11.24M
40.40%7.91M
37.43%4.83M
33.38%2.13M
37.25%7.84M
Operating expense
15.36%279.06M
31.16%1.11B
29.13%777.95M
20.99%499.73M
29.96%241.91M
20.71%848.8M
10.21%602.43M
15.81%413.04M
7.31%186.14M
17.67%703.15M
Administration expense
23.86%67.37M
32.35%278.34M
24.79%190.15M
43.78%119.45M
29.70%54.39M
51.98%210.31M
58.10%152.37M
40.23%83.08M
49.70%41.94M
34.11%138.38M
Financial expense
-147.29%-1.86M
54.78%-2.18M
39.54%-1.86M
17.61%-1.42M
30.08%-750.94K
-15.10%-4.81M
8.94%-3.08M
20.35%-1.73M
-3.25%-1.07M
-282.73%-4.18M
-Interest expense (Financial expense)
3.12%117.67K
-10.57%452.68K
-3.77%357.36K
-8.10%229.42K
-2.77%114.11K
-18.46%506.17K
-25.11%371.36K
-28.61%249.63K
-37.44%117.36K
-42.23%620.73K
-Interest Income (Financial expense)
-100.95%-1.96M
55.62%-2.94M
51.36%-2.33M
42.52%-1.79M
25.64%-975.13K
-45.04%-6.63M
-34.96%-4.79M
-24.37%-3.11M
4.18%-1.31M
-60.22%-4.57M
Research and development
53.18%66.75M
28.15%294.71M
35.34%193.34M
47.53%113.91M
15.55%43.58M
53.48%229.98M
41.44%142.86M
48.74%77.21M
85.34%37.71M
83.83%149.84M
Credit Impairment Loss
512.20%779.81K
-678.02%-3.61M
11.81%-547.47K
88.74%-113.8K
135.01%127.38K
-132.95%-463.8K
13.87%-620.78K
-518.11%-1.01M
-1,028.37%-363.79K
-39.22%1.41M
Asset Impairment Loss
----
----
----
----
----
---12.76M
----
----
----
----
Other net revenue
Fair value change income
--40.46K
-66.69%882.87K
689.64%1.29M
708.65%865.58K
----
566.55%2.65M
-86.27%163.84K
-76.82%107.04K
----
-77.89%397.64K
Invest income
-2.99%1.35M
14.27%4.05M
1.13%2.28M
-11.91%1.67M
-26.34%1.4M
0.74%3.55M
5.72%2.26M
5.52%1.9M
47.80%1.9M
-29.38%3.52M
Asset deal income
-77.69%10.03K
639.43%65.37K
456.60%45.5K
941.82%44.95K
--44.95K
-90.80%8.84K
-91.49%8.17K
-94.34%4.31K
----
216.07%96.06K
Other revenue
55.04%5.17M
46.04%33.56M
-6.00%14.29M
125.39%9.72M
21.96%3.33M
-40.87%22.98M
-55.84%15.2M
-85.99%4.31M
68.24%2.73M
102.70%38.87M
Operating profit
29.00%219.96M
42.60%970.74M
40.00%672.95M
43.41%385.24M
43.30%170.52M
67.28%680.72M
54.03%480.68M
31.82%268.64M
33.69%118.99M
63.73%406.92M
Add:Non operating Income
-54.32%229.2K
50.59%682.28K
129.28%641.07K
119.43%533.53K
188.13%501.72K
47.52%453.06K
182.29%279.61K
241.61%243.14K
310.17%174.13K
85.15%307.12K
Less:Non operating expense
-19.57%10.98M
-0.31%40.39M
-16.39%27.84M
-9.20%20.18M
-10.58%13.65M
-21.02%40.52M
-26.15%33.29M
-22.88%22.22M
-7.43%15.26M
53.57%51.31M
Total profit
32.95%209.22M
45.32%931.03M
44.25%645.75M
48.22%365.6M
51.46%157.37M
80.00%640.65M
67.61%447.67M
40.91%246.66M
43.19%103.9M
65.33%355.93M
Less:Income tax cost
-5.16%27.09M
21.38%103.42M
16.30%91.6M
37.72%61.26M
44.77%28.56M
23.65%85.21M
18.11%78.77M
7.45%44.48M
30.58%19.73M
102.16%68.91M
Net profit
41.40%182.13M
49.00%827.6M
50.21%554.15M
50.53%304.34M
53.03%128.81M
93.52%555.45M
84.08%368.91M
51.27%202.18M
46.51%84.17M
58.40%287.02M
Net profit from continuing operation
41.40%182.13M
49.00%827.6M
50.21%554.15M
50.53%304.34M
53.03%128.81M
93.52%555.45M
84.08%368.91M
51.27%202.18M
46.51%84.17M
58.40%287.02M
Net profit of parent company owners
41.40%182.13M
49.00%827.6M
50.21%554.15M
50.53%304.34M
53.03%128.81M
93.52%555.45M
84.08%368.91M
51.27%202.18M
46.51%84.17M
58.40%287.02M
Earning per share
Basic earning per share
40.63%0.45
48.18%2.03
49.45%1.36
50.00%0.75
52.38%0.32
92.96%1.37
85.71%0.91
51.52%0.5
50.00%0.21
57.78%0.71
Diluted earning per share
40.63%0.45
48.18%2.03
49.45%1.36
50.00%0.75
52.38%0.32
92.96%1.37
85.71%0.91
51.52%0.5
50.00%0.21
57.78%0.71
Other composite income
Total composite income
41.40%182.13M
49.00%827.6M
50.21%554.15M
50.53%304.34M
53.03%128.81M
93.52%555.45M
84.08%368.91M
51.27%202.18M
46.51%84.17M
58.40%287.02M
Total composite income of parent company owners
41.40%182.13M
49.00%827.6M
50.21%554.15M
50.53%304.34M
53.03%128.81M
93.52%555.45M
84.08%368.91M
51.27%202.18M
46.51%84.17M
58.40%287.02M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
--
--
--
--
Rong Cheng Certified Public Accountants (Special General Partnership)
--
--
--
Rong Cheng Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2025(FY)Dec 31, 2024(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022
Total operating revenue 23.48%673.35M34.13%2.82B33.90%1.95B31.68%1.19B30.05%545.3M37.55%2.1B27.69%1.46B26.40%903.58M21.53%419.31M34.86%1.53B
Operating revenue 23.48%673.35M34.13%2.82B33.90%1.95B31.68%1.19B30.05%545.3M37.55%2.1B27.69%1.46B26.40%903.58M21.53%419.31M34.86%1.53B
Total operating cost 21.34%460.73M31.05%1.88B30.42%1.3B27.57%816.75M24.66%379.69M23.30%1.44B14.73%996.11M17.68%640.25M17.61%304.58M27.66%1.16B
Operating cost 21.71%45.96M31.03%183.51M38.79%129.93M23.73%78.97M0.09%37.77M-17.24%140.05M-23.25%93.62M-14.77%63.82M3.11%37.73M35.25%169.24M
Operating tax surcharges 23.38%3.45M22.23%13.73M21.45%9.61M26.78%6.12M31.27%2.79M43.30%11.24M40.40%7.91M37.43%4.83M33.38%2.13M37.25%7.84M
Operating expense 15.36%279.06M31.16%1.11B29.13%777.95M20.99%499.73M29.96%241.91M20.71%848.8M10.21%602.43M15.81%413.04M7.31%186.14M17.67%703.15M
Administration expense 23.86%67.37M32.35%278.34M24.79%190.15M43.78%119.45M29.70%54.39M51.98%210.31M58.10%152.37M40.23%83.08M49.70%41.94M34.11%138.38M
Financial expense -147.29%-1.86M54.78%-2.18M39.54%-1.86M17.61%-1.42M30.08%-750.94K-15.10%-4.81M8.94%-3.08M20.35%-1.73M-3.25%-1.07M-282.73%-4.18M
-Interest expense (Financial expense) 3.12%117.67K-10.57%452.68K-3.77%357.36K-8.10%229.42K-2.77%114.11K-18.46%506.17K-25.11%371.36K-28.61%249.63K-37.44%117.36K-42.23%620.73K
-Interest Income (Financial expense) -100.95%-1.96M55.62%-2.94M51.36%-2.33M42.52%-1.79M25.64%-975.13K-45.04%-6.63M-34.96%-4.79M-24.37%-3.11M4.18%-1.31M-60.22%-4.57M
Research and development 53.18%66.75M28.15%294.71M35.34%193.34M47.53%113.91M15.55%43.58M53.48%229.98M41.44%142.86M48.74%77.21M85.34%37.71M83.83%149.84M
Credit Impairment Loss 512.20%779.81K-678.02%-3.61M11.81%-547.47K88.74%-113.8K135.01%127.38K-132.95%-463.8K13.87%-620.78K-518.11%-1.01M-1,028.37%-363.79K-39.22%1.41M
Asset Impairment Loss -----------------------12.76M----------------
Other net revenue
Fair value change income --40.46K-66.69%882.87K689.64%1.29M708.65%865.58K----566.55%2.65M-86.27%163.84K-76.82%107.04K-----77.89%397.64K
Invest income -2.99%1.35M14.27%4.05M1.13%2.28M-11.91%1.67M-26.34%1.4M0.74%3.55M5.72%2.26M5.52%1.9M47.80%1.9M-29.38%3.52M
Asset deal income -77.69%10.03K639.43%65.37K456.60%45.5K941.82%44.95K--44.95K-90.80%8.84K-91.49%8.17K-94.34%4.31K----216.07%96.06K
Other revenue 55.04%5.17M46.04%33.56M-6.00%14.29M125.39%9.72M21.96%3.33M-40.87%22.98M-55.84%15.2M-85.99%4.31M68.24%2.73M102.70%38.87M
Operating profit 29.00%219.96M42.60%970.74M40.00%672.95M43.41%385.24M43.30%170.52M67.28%680.72M54.03%480.68M31.82%268.64M33.69%118.99M63.73%406.92M
Add:Non operating Income -54.32%229.2K50.59%682.28K129.28%641.07K119.43%533.53K188.13%501.72K47.52%453.06K182.29%279.61K241.61%243.14K310.17%174.13K85.15%307.12K
Less:Non operating expense -19.57%10.98M-0.31%40.39M-16.39%27.84M-9.20%20.18M-10.58%13.65M-21.02%40.52M-26.15%33.29M-22.88%22.22M-7.43%15.26M53.57%51.31M
Total profit 32.95%209.22M45.32%931.03M44.25%645.75M48.22%365.6M51.46%157.37M80.00%640.65M67.61%447.67M40.91%246.66M43.19%103.9M65.33%355.93M
Less:Income tax cost -5.16%27.09M21.38%103.42M16.30%91.6M37.72%61.26M44.77%28.56M23.65%85.21M18.11%78.77M7.45%44.48M30.58%19.73M102.16%68.91M
Net profit 41.40%182.13M49.00%827.6M50.21%554.15M50.53%304.34M53.03%128.81M93.52%555.45M84.08%368.91M51.27%202.18M46.51%84.17M58.40%287.02M
Net profit from continuing operation 41.40%182.13M49.00%827.6M50.21%554.15M50.53%304.34M53.03%128.81M93.52%555.45M84.08%368.91M51.27%202.18M46.51%84.17M58.40%287.02M
Net profit of parent company owners 41.40%182.13M49.00%827.6M50.21%554.15M50.53%304.34M53.03%128.81M93.52%555.45M84.08%368.91M51.27%202.18M46.51%84.17M58.40%287.02M
Earning per share
Basic earning per share 40.63%0.4548.18%2.0349.45%1.3650.00%0.7552.38%0.3292.96%1.3785.71%0.9151.52%0.550.00%0.2157.78%0.71
Diluted earning per share 40.63%0.4548.18%2.0349.45%1.3650.00%0.7552.38%0.3292.96%1.3785.71%0.9151.52%0.550.00%0.2157.78%0.71
Other composite income
Total composite income 41.40%182.13M49.00%827.6M50.21%554.15M50.53%304.34M53.03%128.81M93.52%555.45M84.08%368.91M51.27%202.18M46.51%84.17M58.40%287.02M
Total composite income of parent company owners 41.40%182.13M49.00%827.6M50.21%554.15M50.53%304.34M53.03%128.81M93.52%555.45M84.08%368.91M51.27%202.18M46.51%84.17M58.40%287.02M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----------Unqualified opinion------Unqualified opinion
Auditor ----------Rong Cheng Certified Public Accountants (Special General Partnership)------Rong Cheng Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
Sample Name
Sample Code
 +29.97%
Sample Name
Sample Code
 +22.28%
Sample Name
Sample Code
 +20.02%
4
Guangdong Topstar Technology
300607
+20.01%
5
Hengerda New Materials
300946
+20.01%
Unlock Now

Discussing

Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve Show More
Berkshire's 2025 Annual Shareholders Meeting

Investment Course

How to Buy Stocks for Beginners
Learn stock market basics and confidently start investing with our beginner-friendly guide to buying stocks. Start your investment journey today!
What Is Options Trading and How to Trade Options
Options trading is carried out by all kinds of investors within individual investment portfolios. Learn how you can put options to work within your own portfolio.
What To Know About Margin Accounts
Discover the essentials of margin accounts, including their benefits, risks, and how to use them effectively in your trading strategy.
Cash Accounts - Covering the Basics
Discover the essentials of cash accounts. Learn what cash accounts are, how they function, their potential benefits, and the differences between cash and margin accounts.
Understanding Fractional Shares: A Beginner's Guide
Discover the basics of fractional shares, how they work, and the process for buying and selling them.

- No more -